Type Whole antibody Target CD2 CAS Number 288392-69-8 | Source Humanized (from rat) ATC code none ChemSpider none | |
How to pronounce siplizumab
Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.
Contents
Pronounce medical words siplizumab
References
Siplizumab Wikipedia(Text) CC BY-SA